Posted Jul. 15, 2014 at 7:21 a.m.

Premium Lock GSK invests up to $25M in new drug manufacturing technology - in Pa., not N.C.

Published: 2014-07-15 07:21:19
Updated: 2014-07-15 07:21:19

GSK's R&D facility in RTP    GSK's R&D facility in RTP. (GSK photo)

GlaxoSmithKline, which operates a huge drug manufacturing facility in Zebulon, is investing as much as $25 million to license a technology platform from a California firm as part of efforts to develop new drugs. But GSK isn't bringing the platform to N.C., at least initially....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2017 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders